OPAM-IA: A Physical Activity Intervention
Study Title: Effectiveness of Online Physical Activity Monitoring in Inflammatory Arthritis (OPAM-IA): A New Model of Care
Principal Investigator: Linda Li PT, PhD; Professor, University of British Columbia; Senior Research Scientist, Arthritis Research Canada
Study Start Date: January 2017 | End Date: TBD
Why do this research?
Physical activity is important in managing arthritis.
Reasons for inactivity include motivation, exercise doubts and limited counselling.
To address the problem of inactivity, we will test a new program at improving physical activity among rheumatoid (RA) and systemic lupus erythematosus (SLE) patients.
What will be done?
OPAM-IA is a program that uses Fitbit Flex (wireless physical activity tracker) paired with FitViz (new application), and physical activity counselling to help people with RA and SLE be more physically active safely and at their own pace. Physical activity information will be collected by the Fitbit Flex and viewed through the FitViz by a physiotherapist to guide participant’s progress.
The OPAM-IA program consists of:
- A one-time group education session in the Greater Vancouver Area
- Using Fitbit Flex and FitViz app
- Online/telephone physical activity counselling.
Who is involved
Our team consists of 7 co-investigators, 6 research staff and 12 collaborators. Sixty people with RA and sixty people with SLE will be recruited. Eligibility criteria consists of:
- RA or SLE diagnosis.
- No previous experience in using any physical activity wearables.
Participants will be randomly assigned to one of the two groups to either receive the intervention immediately or wait 2 months before getting the intervention. Participants in the Immediate Group will be asked to attend a group education session, use a Fitbit Flex with the FitViz app, and receive counselling by a registered physiotherapist. Participants in the Delayed Group will wait 2 months to start the same intervention. Throughout the study, assessments will be done at the beginning, and at the end of months 2, 4, and 6. These assessments include an online questionnaire and wearing another research based accelerometer for 7 days.
How do people get involved?
For more information, please view the OPAM-IA recruitment notice. If you are Interested in participating, you can click here to access our short screening questionnaire and contact the study coordinator.
Contact: Halima Elmi, MPH, Research Coordinator
Phone: 604.207.4053 | National Toll Free: 1.844.707.4053
Who is funding the research?
The Arthritis Society
Who is on the research team?
Dr. Lynne Feehan, BScPT, MSc, PhD
Lead, Clinical Research, Rehabilitation, Fraser Health; Clinical Associate Professor, UBC
Dr. Antonio Aviña-Zubeita, MD, MSc, PhD
Assistant Professor, UBC
Dr. Charles Goldsmith, MSc, PhD
Professor, Biostatistics, Simon Fraser University
Dr. Anne Townsend, PhD
Research Associate, UBC
Dr. Catherine Backman, PhD, OT(C), FCAOT
Head, Department of Occupational Science and Occupational Therapy, UBC
Dr. Diane Gromala, PhD
Professor, Simon Fraser University
Dr. Chris Shaw, PhD
Associate Professor, Simon Fraser University
Navi Grewal, Research Coordinator, Arthritis Research Canada
Morgan Barber, Research Coordinator, Arthritis Research Canada
Juliane Chien, Research Assistant, Arthritis Research Canada
Jenny Leese, PhD trainee, Arthritis Research Canada
Jasmina Geldman, Research Coordinator, Arthritis Research Canada
Graham Macdonald, Research Assistant, Arthritis Research Canada
Greg Noonan, Mary Pack Arthritis Program
Paul Adam, Mary Pack Arthritis Program
Dr. Leigh Callahan, Thurston Arthritis Research Center
Pam Montie, Arthritis Patient Advisory Board
Cherly Koehn, Arthritis Consumer Experts
Dr. John Esdaile, University of British Columbia, Arthritis Research Canada
Dr. Kam Shojania, University of British Columbia, Arthritis Research Canada
Dr. David Collins, University of British Columbia
Dr. Jason Kur, Pacific Arthritis Centre
Dr. Jennifer Reynolds, Vancouver General Hospital
Dr. Ken Blocka, University of British Columbia
Dr. Shahin Jamal, University of British Columbia